Evidence for dopamine involvement in ambulation promoted by menthone in mice

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 3, 2009, Pages 315-320

  Umezu, Toyoshi ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

Author keywords

Ambulation; Dopamine; Menthone; Mouse; Peppermint

Indexed keywords

AMFEBUTAMONE; CHLORPROMAZINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR; FLUPHENAZINE; HALOPERIDOL; MENTHONE; METIROSINE; OLIVE OIL; PEPPERMINT OIL; SPIPERONE; TREPIPAM MALEATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME INHIBITION; MALE; MOBILIZATION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT RESPONSE;

ALPHA-METHYLTYROSINE; ANIMALS; DOPAMINE; DOPAMINE ANTAGONISTS; ENZYME INHIBITORS; INJECTIONS, INTRAPERITONEAL; MALE; MENTHOL; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; STIMULATION, CHEMICAL;

MENTHA X PIPERITA; MUS;

EID: 57449100906     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.07.017     Document Type: Article

References (47)

1. Abu Hena Mostofa Kamal M., Iimura N., Nabekura T., and Kitagawa S. Enhanced skin permeation of salicylate by ion-pair formation in non-aqueous vehicle and further enhancement by ethanol and l-menthol. Chem Pharm Bull (Tokyo) 54 (2006) 481-484
2. Ammar H.O., Salama H.A., Ghorab M., El-Nahhas S.A., and Elmotasem H. A transdermal delivery system for glipizide. Curr Drug Deliv 3 (2006) 333-341
3. Asami T., Kuribara H., and Tadokoro S. Effects of repeated administration of bromocryptine on ambulatory activity in mice. Jpn J Psychopharmacol 6 (1986) 309-317
4. Balchin M.L. Essential oils and 'aromatherapy': their modern role in healing. J R Soc Health 117 (1997) 324-329
5. Buckle J. Use of aromatherapy as a complementary treatment of chronic pain. Altern Ther 5 (1999) 42-51
6. Fulford A.J., and Marsden C.A. An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation reared rats. Neurosci 149 (2007) 392-400
7. Gazzara R.A., and Andersen S.L. The effects of bupropion in vivo in the neostriatum of 5-day-old and adult rats. Brain Res Dev Brain Res 100 (1997) 139-142
8. Hirabayashi H., Iizuka M., and Tadokoro S. Simple and easy method for measurement of ambulatory activity in mice. Folia Pharmacol Jpn 74 (1978) 629-639 (text in Japanese with English abstract)
9. Hirate K., and Kuribara H. Characteristics of ambulation-increasing effect of GBR-12909, a selective dopamine uptake inhibitor, in mice. Jpn J Pharmacol 55 (1991) 501-511
10. Iijima Y., Asami T., and Kuribara H. Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice. Jpn J Psychopharmacol 16 (1986) 11-18
11. Krishnaiah Y.S., and Bhaskar P. Studies on the transdermal delivery of nimodipine from a menthol-based TTS in human volunteers. Curr Drug Deliv 1 (2004) 93-102
12. Kuribara H. Can posttreatment with the selective dopamine D2 antagonist, YM-09151-2, inhibit induction of methamphetamine sensitization? Evaluation by ambulatory activity in mice. Pharmacol Biochem Behav 49 (1994) 323-326
13. Kuribara H. Dopamine D1 and D2 receptor antagonists suppress acute stimulant action of cocaine, but enhance cocaine sensitization. Jpn J Psychiatry Neurol 48 (1994) 907-911
14. Kuribara H. Modification by caffeine of the sensitization to methamphetamine and cocaine in terms of ambulation in mice. Life Sci 55 (1994) 933-940
15. Kuribara H. Caffeine enhances the stimulant effect of methamphetamine, but may not affect induction of methamphetamine sensitization of ambulation in mice. Psychopharmacology 116 (1994) 125-129
16. Kuribara H. Effects of sulpiride and nemonapride, benzamide derivatives having distinct potencies of antagonistic action on dopamine D2 receptors, on sensitization to methamphetamine in mice. J Pharm Pharmacol 48 (1995) 292-296
17. Kuribara H. Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice. Eur J Pharmacol 275 (1995) 251-258
18. Kuribara H. Caffeine enhances acute stimulant effect of morphine but inhibit morphine sensitization when assessed by ambulation of mice. Prog Neuro-Psychopharmacol Psychiatry 19 (1995) 313-321
19. Kuribara H. Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol. Psychopharmacology 19 (1995) 34-38
20. Kuribara H. Interaction between D1 and D2 antagonists in the inhibition of methamphetamine-induced ambulation in mice. Pharm Sci 2 (1996) 141-144
21. Kuribara H., and Tadokoro S. Development of tolerance to ambulation-increasing effect of scopolamine dependent on environmental factors in mice. Jpn J Pharmacol 33 (1983) 1041-1048
22. Kuribara H., and Tadokoro S. Circadian variation in the ambulation-increasing effect of apomorphine after repeated administration in mice. Jpn J Psychopharmacol 4 (1984) 231-236
23. Kuribara H., and Uchihashi Y. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice. J Pharm Pharmacol 45 (1993) 1042-1045
24. Kuribara H., and Uchihashi Y. Effects of haloperidol on the methamphetamine sensitization: assessment by ambulatory activity in mice. Jpn J Psychiatry Neurol 47 (1993) 661-668
25. Kuribara H., and Uchihashi Y. Effects of dopamine antagonism on methamphetamine sensitization: evaluation by ambulatory activity in mice. Pharmacol Biochem Behav 47 (1994) 101-106
26. Kuribara H., Asami T., Saito T., Ida I., and Tadokoro S. Behavioral study on mergocriptine (CBM36-733) by ambulatory activity in mice: repeated administration and interaction with methamphetamine. Jpn J Pharmacol 54 (1990) 163-170
27. Kuribara H., Katsuya T., Asahi T., and Tadokoro S. Effects of repeated administration of buprenorphine on ambulatory activity in mice. Jpn J Psychopharmacol 13 (1991) 123-127
28. Kuribara H., Asami T., Ida I., and Tadokoro S. Characteristics of the ambulation-increasing effect of the non-competitive NMDA antagonist MK-801 in mice: assessment by the coadministration with central-acting drugs. Jpn J Pharmacol. 50 (1992) 11-18
29. Liu H., Li S., Wang Y., Yao H., and Zhang Y. Effect of vehicle and enhancers on the topical delivery of cyclosporine A. Int J Pharm 27 (2006) 182-186
30. Miyazawa M., and Nakanishi K. Biotransformation of (-)-menthone by human liver microsomes. Biosci Biotechnol Biochem 70 (2006) 1259-1261
31. Munzar P., and Goldberg S.R. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 148 (2000) 209-216
32. Narishetty S.T., and Panchagnula R. Transdernal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release 95 (2004) 367-379
33. Parke D.V. The biochemistry of foreign compounds (1968), Pergamon Press, Oxford 149
34. Perry N., and Perry E. Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives. CNS Drugs 20 (2006) 257-280
35. Pillai O., and Panchagnula R. Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo permeation studies in rat using iontophoresis and chemical enhancers. J Control Release 89 (2003) 127-140
36. Tisserand R. The Art of Aromatherapy (1993), CW Daniel Company Ltd, Essex, UK
37. Thomas D.M., Francesutti-Verbeem D.M., and Kuhn D.M. The newly sysnthesized pool of dopamine determine the severity of methamphetamine-induced neurotoxicity. J. Neurochem. 105 (2008) 605-616
38. Umezu T. Anticonflict effects of plant-derived essential oil. Pharmacol Biochem Behav 64 (1999) 35-40
39. Umezu T. Behavioral effects of plant-derived essential oils in the Geller type conflict test in mice. Jpn J Pharmacol 83 (2000) 150-153
40. Umezu T., and Morita M. Evidence for the involvement of dopamine in ambulation promoted by menthol in mice. J Pharmacol Sci 91 (2003) 125-135
41. Umezu T., Yonemoto J., Soma Y., and Suzuki T. Tris(2-chloroethyl)phosphate increases ambulatory activity in mice. Pharmacological analyses of its neurochemical mechanism. Toxicol Appl Pharmacol 148 (1998) 109-116
42. Umezu T., Sakata A., and Ito H. Ambulation-promoting effect of peppermint oil and identification of its active constituents. Pharmacol Biochem Behav 69 (2001) 383-390
43. Umezu T., Ito H., Nagano K., Yamakoshi M., Oouchi H., Sakaniwa M., et al. Anticonflict effects of rose oil and identification of its active constituents. Life Sci 72 (2002) 91-102
44. Umezu T., Nagano K., Ito H., Kosakai K., Sakaniwa M., and Morita M. Anticonflict effects of lavender oil and identification of its active constituents. Pharmacol Biochem Behav 85 (2006) 713-721
45. Wacan J.J., Reichel C.M., Farley C.M., and McDougall S.A. The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen. Psychophamacology 185 (2006) 104-111
46. Watanabe S., Fusa K., Takada K., Aono Y., Saigusa T., Koshikawa N., et al. Effects of alpha-methyl-p-tyrosine on extracellular dopamine levels in the nucleus accumbens and the dorsal striatum of freely moving rats. J Oral Sci 47 (2005) 185-190
47. Zhao K., Singh S., and Singh J. Effect of menthone on the in vitro percutaneous absorption of tamoxifen and skin reversibility. Int J Pharm 219 (2001) 177-181